Patents Assigned to Medipharma S.A.
  • Patent number: 7763650
    Abstract: A new pharmaceutical compound for treating central nervous disorders, the compound comprising a therapeutically effective amount of valproic acid or pharmaceutically acceptable derivative thereof covalently bonded to myo-inositol. The invention also provides a composition, method for treating a patient and a method for obtaining the compound.
    Type: Grant
    Filed: March 15, 2006
    Date of Patent: July 27, 2010
    Assignees: Medipharma S.A., University Nacional De La Plata
    Inventors: Luis Bruno-Blanch, Sung Chin Moon
  • Publication number: 20070219164
    Abstract: A new pharmaceutical compound for treating central nervous disorders, the compound comprising a therapeutically effective amount of valproic acid or pharmaceutically acceptable derivative thereof covalently bonded to myo-inositol. The invention also provides a composition, method for treating a patient and a method for obtaining the compound.
    Type: Application
    Filed: March 15, 2006
    Publication date: September 20, 2007
    Applicants: Medipharma S.A., Universidad Nacional De La Plata
    Inventors: Luis Bruno-Blanch, Sung Moon
  • Patent number: 6140371
    Abstract: A number of new therapeutic uses have been found for compounds such as known local anesthetics which are quite different from the present therapeutic uses of these drugs. The uses include, for example; modulating lymphocytes, macrophages and other immune cell functions, or PMN functions; inhibiting the cytotoxic effect of polymorphonuclear neutrophils leucocytes; providing a protective effect on plasma cell membranes; and providing an antidote against intoxication by an intoxicants.
    Type: Grant
    Filed: February 19, 1998
    Date of Patent: October 31, 2000
    Assignee: Medipharma S.A.
    Inventors: Juan Carlos Mahiques, Ricardo Luis Elicabe, Raul Isidoro Koler, Ruben Martin Laguens, Enrique Leo Portiansky